Related Experiment Video
Updated: Jun 29, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Consideration and Application of Lipoprotein(a) in the Risk Assessment of Atherosclerotic Cardiovascular Disease Risk
Tiffany Yuen1, G B John Mancini2, Robert A Hegele3
1Faculty of Medicine & Dentistry, University of Alberta, Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada.
Insights
High lipoprotein(a) (Lp[a]) levels are a significant risk factor for cardiovascular disease. Measuring Lp(a) once is recommended for assessing atherosclerotic cardiovascular disease (ASCVD) risk.
Area of Science:
- Cardiology
- Biochemistry
- Genetics
Background:
- Lipoprotein(a) (Lp[a]) is an LDL-like particle containing apoB and apo(a).
- Elevated Lp(a) is an independent, causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and aortic valve disease.
- Lp(a) promotes atherogenesis, inflammation, and thrombosis, with risk linearly associated with Lp(a) levels.
Purpose of the Study:
- To review the utility and application of Lp(a) measurement in ASCVD risk assessment.
- To provide an update on Lp(a) in the context of adult cardiovascular risk management.
- To align with the 2021 Canadian Cardiovascular Society Dyslipidemia Guidelines recommendation for Lp(a) screening.
Main Methods:
- Literature review of studies on Lp(a) and cardiovascular risk.
- Analysis of the role of Lp(a) in atherogenesis, inflammation, and thrombosis.
- Examination of current guidelines regarding Lp(a) testing.
Main Results:
- Reliable assays for Lp(a) are available, enabling clinical assessment.
- Lp(a) levels show a linear association with ASCVD risk.
- The 2021 Canadian Cardiovascular Society guidelines recommend a one-time Lp(a) measurement for lipid screening.
Conclusions:
- Lp(a) is a crucial, actionable risk marker for ASCVD.
- Routine Lp(a) measurement aids in identifying individuals at elevated cardiovascular risk.
- Understanding Lp(a) is vital for comprehensive ASCVD risk assessment and management.
Abstract:
Lipoprotein(a) (Lp[a]) is an low-density lipoprotein (LDL)-like particle in which apolipoprotein (apo) B is covalently bound to a plasminogen-like molecule called apo(a). A High level of Lp(a) has been demonstrated to be an independent, causal, and prevalent risk factor for atherosclerotic cardiovascular disease (ASCVD), as well as aortic valve disease, through mechanisms that promote atherogenesis, inflammation, and thrombosis. With reliable and accessible assays, Lp(a) level has been established to be associated linearly with the risk for ASCVD. The 2021 Canadian Cardiovascular Society Dyslipidemia Guidelines recommend measuring an Lp(a) level once in a person's lifetime as part of the initial lipid screening. The aim of this review is to provide an update and overview of the utility and application of Lp(a) level in the assessment and treatment of adults at risk for ASCVD, consistent with this guideline recommendation.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Inflammation
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

